TGFβ-IN-2 inhibits TGF-β-induced total collagen accumulation in NRK-49F cells (IC50 = 4.31 μM); suppresses TGF-β-induced expression of COL1A1, α-SMA, and p-Smad3 proteins in vitro; and shows potential as an effective anti-fibrotic agent in vivo upon oral administration.